DNTH

Dianthus Therapeutics (DNTH)

About Dianthus Therapeutics (DNTH)

Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company. It designs and delivers novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company was founded on June 17, 2015 and is headquartered in New York, NY.

Details

Daily high

$42.26

Daily low

$40.16

Price at open

$41.64

52 Week High

$45.46

52 Week Low

$13.36

Market cap

1.8B

Dividend yield

0.00%

Volume

648,724

Avg. volume

669,986

P/E ratio

-12.00

Dianthus Therapeutics News